Nick Leschly

2019 - bluebird bio

In 2019, Nick Leschly earned a total compensation of $13.2M as Chief Executive Officer at bluebird bio, a 45% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$418,275
Option Awards$8,698,341
Salary$660,000
Stock Awards$3,365,750
Other$11,200
Total$13,153,566

Leschly received $8.7M in option awards, accounting for 66% of the total pay in 2019.

Leschly also received $418.3K in non-equity incentive plan, $660K in salary, $3.4M in stock awards and $11.2K in other compensation.

Rankings

In 2019, Nick Leschly's compensation ranked 445th out of 13,971 executives tracked by ExecPay. In other words, Leschly earned more than 96.8% of executives.

ClassificationRankingPercentile
All
445
out of 13,971
97th
Division
Manufacturing
166
out of 5,701
97th
Major group
Chemicals And Allied Products
44
out of 2,200
98th
Industry group
Drugs
36
out of 1,886
98th
Industry
Biological Products, Except Diagnostic Substances
7
out of 389
98th
Source: SEC filing on April 27, 2020.

Leschly's colleagues

We found five more compensation records of executives who worked with Nick Leschly at bluebird bio in 2019.

2019

William Baird

bluebird bio

Chief Financial Officer

2019

Jeffrey Walsh

bluebird bio

Former Chief Strategy Officer

2019

David Davidson

bluebird bio

Chief Medical Officer

2019

Philip Gregory

bluebird bio

Chief Scientific Officer

2019

Jason Cole

bluebird bio

Chief Operating and Legal Officer

News

In-depth

You may also like